[coolwulf]

Thank you for your comment and I would like to clarify a few things:

1) NeuralRad could be running locally inside your own clinic. Currently, Stanford hospital, UTSW, Jefferson and several other clinics in the US are using it in house. In this configuration, the data never transferred outside the clinic.

2) The whole platform is HIPAA-complaint. All Dicom data are anonymized before submitting to NeuralRad server for inference if using the NeuralRad cloud server.

3) NeuralRad server is within US, not in "other" country.

Thanks.

[dekhn]

If you can't spell HIPAA right, how am I supposed to trust you that you are "HIPAA-compliant" (whatever that means)?

[coolwulf]

Thank you for pointing out the typo. I am on mobile with fat fingers :p

[medimikka]

> Stanford hospital

No. Know how I know this?

[dang]

Would you please make your substantive points less aggressively? I appreciate that you know a great deal about this topic and we all probably have a lot to learn from you. Nonetheless you crossed the line here, and not only here—repeatedly mocking someone for their username, for example, is a cheap shot. You undermine your own arguments when you do things like this, in addition to poisoning the culture that we're trying so hard to prevent from becoming outright toxic.

https://news.ycombinator.com/newsguidelines.html

[medimikka]

Not quite. I am pointing out, that we're not talking about "yet another AI app" here, but something that might potentially be used to inform treatment decisions. In other words, something that decides over the life and death of a human being.

This life and death situation demands a certain decorum. Among others, to rise above the "hi I am coolwulf" stage of interpersonal interactions.

Let me go to a different topic in the same ballpark: imagine you had to build your SARS-CoV-2 response plan based on either a panel of women and men whose name and credentials you are privy to, or a single individual with a blog calling themselves "y0m0mm4" - which one would you, reasonably, choose to consider? Yes, the single individual may have, by chance or skill, happened upon the perfect plan. And, yes, the panel of experts may be completely wrong. But in medicine we call this a Zebra, a very rare event that, in a discipline of probabilistic empiricism, should not initially be considered.

I don't doubt, that all the above might come together to greatly improve treatment decisions. In fact, I know it, because as I said repeatedly, Bruker, Siemens, Tally, and others work on those solutions as well, and they are being used. Initially only in secondary verification, but with three FDA approvals expected this quarter, there might be much more coming.

I just don't think a pseudonymous account on Hacker News is the place to farm something that, not unlike many other medical interventions, has a massive potential of harm. As a somewhat related side note: the US was spared the horrors of thalidomide, because a single woman at the FDA (Frances Oldham Kelsey) refused to certify a medication that did not list the names of the inventors. When she did not get answers to her questions, largely because Grünenthal refused to let her speak to the drug's developers, she refused certification. In medicine names mean something, and if it's just the ability to verify background claims.

[dang]

I don't think any professional is making treatment decisions based on random internet forum posts.

The purpose of HN is to have curious conversation about interesting things, and for that the high-order bit is that commenters be thoughtful and not aggressive.

https://news.ycombinator.com/newsguidelines.html

[coolwulf]

At Stanford, the platform is used to help Physicians and Medical Physicists to contour Brain Mets. In addition, the platform never approves any dicom RT Structures. Physicians can use the generated RT structure to assist their SRS workflow.

[iwontberude]

I don’t know, I assume you are implying that you are on the hospital or SoM IRB or are privy to their work? I am curious to hear more of your opinions if you can share.